Acorda Therapeutics is losing another employee. After seeing colleagues depart in waves of layoffs in recent years, Acorda Chief Medical Officer Burkhard Blank is leaving to take up a position at…
Researchers identified a molecule that interacts with the regulator of certain immune cells as a potential target to treat immune and bone metabolic diseases. The team at Tokyo University of Science…
A patient has died in a Kura Oncology phase 1b trial in people with acute myeloid leukemia leading the FDA to place a clinical hold on the study. The investigational oral treatment was potentially…
Merck wants in on another immunotherapy program from its $695 million collaboration with Dragonfly Therapeutics. The biotech has been popular around Big Pharma in the past two months with Bristol…
Pfizer has reported top-line results on its $250 million antisense bet. The phase 2b clinical trial of the cardiovascular disease drug met its primary endpoint but, with Pfizer still considering next…
Kymera Therapeutics showed its STAT3 degrader significantly inhibited tumor growth in mice bearing colorectal cancer and B-cell lymphoma. The drug also appeared to sensitize tumors to anti-PD-1 cancer…
Nearly three months into her federal trial over a dozen counts of fraud, Elizabeth Holmes took the stand last week, undergoing questioning by her defense team that has so far stretched across three…
Spurred by Covid-19, we are witnessing the unprecedented digital transformation of healthcare, and health systems that don’t rapidly innovate to meet this ‘new normal’ risk being left behind. While…
A federal jury found pharmacy chains CVS, Walgreens and Walmart helped fuel the opioid epidemic in two Ohio counties. It’s the first trial pharmacy chains have faced related to the opioid crisis,…
The FDA placed a partial clinical hold on a Kura Oncology leukemia drug following the death of one patient in the early-stage study. Kura executives said the death may be related to differentiation…
